S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ANIP ANI Pharmaceuticals Inc

58.92

-0.27 (-0.46%)

15 Feb 2025 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

05/16/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Renate Tannenbaum

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more ANI Pharmaceuticals Charts.

ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more ANI Pharmaceuticals Charts.

ANI Pharmaceuticals Inc News

Form 8-K - Current report
Wednesday 5 February 2025 (1 week ago) • Edgar (US Regulatory)

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
Wednesday 29 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 22 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 14 January 2025 (1 month ago) • Edgar (US Regulatory)

Alcami Announces CEO Transition
Tuesday 14 January 2025 (1 month ago) • PR Newswire (US)

ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook
Monday 13 January 2025 (1 month ago) • GlobeNewswire Inc.

ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity
Thursday 2 January 2025 (1 month ago) • GlobeNewswire Inc.

ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 31 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 18 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

More ANI Pharmaceuticals Inc News Articles

National Australia Bank

JP Morgan Chase

Australia And New Zealan...

S&P ASX 300 Metals and M...

Invesco QQQ Trust Series 1

Newcrest Mining

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions